Silver Book Fact

Visual loss from subfoveal choroidal neovascularization, a characteristic of wet age-related macular degeneration (AMD), was found to have a profound impact on how patients felt about their health-related quality of life–rating it as low or lower than patients with renal failure and AIDS.

Bass E, Marsh M, Mangione C, Bressler N, et al. Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale. Arch Opthalmol. 2004; 122(12): 1856-67. http://archopht.ama-assn.org/cgi/content/abstract/122/12/1856

Reference

Title
Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale
Publication
Arch Opthalmol
Publication Date
2004
Authors
Bass E, Marsh M, Mangione C, Bressler N, et al
Volume & Issue
Volume 122, Issue 12
Pages
1856-67
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • More than 1 in 10 Americans over the age of 80 has advanced age-related macular degeneration (AMD)– 1.08 million Americans 80 and older.  
  • Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in people over the age of 65.  
  • Prevalence of Age-Related Eye Disease by Gender and Age  
  • An estimated 424,801 more visually impaired and blind individuals live in nursing homes than would be expected if they had normal vision.  
  • Increase in trouble seeing with age, 2006
    16.8% of the non-institutionalized adults 65 years and older have some trouble seeing, even with glasses or contacts. That number increases to 19.9% in adults 75 years and older.